An overview of the clinical research landscape in this emerging region that also looks at its challenges.
Simply handing off multi-million-dollar studies to CROs without carefully crafted plans for communications and reporting operational data as the study unfolds is hardly a wise move, yet what kind of oversight is needed? Live: Tuesday, Apr. 28, 2020 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until Apr. 28, 2021. Register free
Today's drug sponsors need to prepare and practice for worst-case clinical trial scenarios.
Analysis of hematology and blood chemistry's AEs in sponsor's databases.
An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.
In July, at a meeting called by the U.S. Department of Health and Human Services on Human Research Protections, I reviewed the fascinating results of a randomized study that recently compared paper-based informed consent to electronic informed consent.
Understanding and using adaptive trial design to achieve the most of its available advantages.
With more clinical trials conducted overseas, sponsors are facing new obstacles.
An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.
Patient-level feedback from later studies provides a multitude of valuable answers to all stakeholders.
The Pediatric Working Group of EUCROF launched an initiative to achieve standardization of generic Informed Consent Form and Assent Form templates within European countries. The differences are noted based on a prior survey.
The right person can successfully promote proper management of quality and compliance, leading to desired clinical trial outcomes.
A comparison of the yields and costs of online outreach methods to other recruitment techniques.
To minimize time to market, sponsors must explore new subject recruitment techniques.
Understanding the United States' regulatory pathways and clinical operations.
Jim Kremidas, former executive director, Association of Clinical Research Professionals, shares his experiences as a patient in clinical trials.
With a PC and some software you can generate realistic projections that save time and money.
Analysis of hematology and blood chemistry's AEs in sponsor's databases.
A probability sampling assessment by FDA takes a look at compliance in the medical device world.
Step-by-step process for budgeting global trials that uses a Currency Risk Management method.
Even before trials start, compiling a "target label" can add value by helping steer product development.
An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.
How the ability to apply text mining and signal detection algorithms to social media's real-time data provides unheard of value.
A rising initiative in Wales led by the International Business of Wales (IBW) promotes company growth in the region.
Analysis of hematology and blood chemistry's AEs in sponsor's databases.